Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 973 clinical trials in Utrecht, The Netherlands across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of ACP-017 and Pembrolizumab for Patients with Advanced or Metastatic Cancer
The NetherlandsStudy on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)
The NetherlandsStudy on the Effects of Ertugliflozin and Sodium Intake on Blood Pressure in Overweight Adults with Type 2 Diabetes
The NetherlandsStudy on Amivantamab, Lazertinib, and Bevacizumab for Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer After Treatment Progression
The NetherlandsStudy on Long-Term Safety and Effectiveness of Vamorolone in Boys with Duchenne Muscular Dystrophy Who Completed Previous Vamorolone Studies
The NetherlandsStudy of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes
The NetherlandsStudy on the Safety and Effects of PDC*lung01 Vaccine with Pemetrexed or Pembrolizumab for Patients with Non-Small Cell Lung Cancer
The NetherlandsStudy of varegacestat (AL102) in patients with progressing desmoid tumors
The NetherlandsStudy on Denosumab for Healing Bone Fractures in Diabetic Patients with Charcot Foot
The NetherlandsStudy on the Safety of Donidalorsen for Patients with Hereditary Angioedema
The NetherlandsStudy of tacrolimus, everolimus and mycophenolate mofetil combination in elderly patients after kidney transplant
The NetherlandsStudy of Sacituzumab Govitecan and Pembrolizumab for Patients with Untreated Advanced Triple-Negative Breast Cancer
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on TTR amyloidosis and heart disease treatments, investigating new therapeutic approaches for cardiac conditions. Clinical trials evaluate novel medications for improving patient mobility and cardiac function.
Research aims to enhance quality of life for patients with hereditary and wild-type ATTR cardiomyopathy.
Comprehensive studies in gastric cancer, bladder cancer, and neuroblastoma, exploring innovative treatment combinations and diagnostic methods.
Advanced trials combining established treatments with novel approaches to improve patient outcomes.
Groundbreaking research in Amyotrophic Lateral Sclerosis and chronic inflammatory conditions, focusing on innovative treatments and disease modification strategies.
Studies aim to develop effective treatments for rare and challenging neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
